Processus Wealth & Capital Management’s Amgen AMGN Stock Holding History

Processus Wealth & Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.97M	Buy	10,976 +254	+2%	+$86.9K	2.35%	16
2026 Q1	$3.77M	Sell	10,722 -33	-0.3%	-$11.8K	2.56%	19
2025 Q4	$3.52M	Buy	10,755 +163	+2%	+$51.7K	2.32%	21
2025 Q3	$2.99M	Buy	10,592 +246	+2%	+$71.3K	2.14%	21
2025 Q2	$2.89M	Buy	10,346 +1,934	+23%	+$548K	2.28%	20
2025 Q1	$2.62M	Buy	8,412 +185	+2%	+$54.6K	2.23%	19
2024 Q4	$2.14M	Sell	8,227 -696	-8%	-$206K	1.71%	23
2024 Q3	$2.88M	Sell	8,923 -959	-10%	-$314K	2.37%	19
2024 Q2	$3.09M	Buy	9,882 +123	+1%	+$36.1K	2.56%	16
2024 Q1	$2.77M	Buy	9,759 +1,293	+15%	+$378K	2.46%	18
2023 Q4	$2.44M	Buy	+8,466	New	+$2.31M	2.44%	19

Other funds holding AMGN

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFM

Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

SMDAM

Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return

Processus Wealth & Capital Management's AMGN Position: Q2 2026 in Review

Processus Wealth & Capital Management increased its Amgen (AMGN) stake by 2.4% in Q2 2026, buying an estimated $86.9K and bringing the position to 10,976 shares worth $3.97M. The position accounts for 2.35% of the portfolio, ranked #16.

Processus Wealth & Capital Management first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Processus Wealth & Capital Management held 10,976 shares of Amgen worth $3.97M as of Q2 2026.
Processus Wealth & Capital Management bought 254 Amgen shares in Q2 2026, an estimated $86.9K.
Amgen made up 2.35% of Processus Wealth & Capital Management's portfolio in Q2 2026, its #16 holding.
Processus Wealth & Capital Management first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Processus Wealth & Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.